About
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 28 2026
Press Release Mar 27 2026
Mar 21 2026
Press Release Mar 21 2026
Mar 16 2026
Press Release Mar 16 2026
Mar 16 2026
Sun Pharma Announces US FDA Acceptance of Supplemental Biologics License (sBLA) Application for ILUMYA® (tildrakizumab-asmn) for the Treatment of Adults with Active Psoriatic Arthritis
Feb 27 2026
Sun Pharma Showcases Data Across its Dermatology & Immunology Portfolio at 2026 Winter Clinical Miami
Financials
Revenue
₹568.09 B
Market Cap
₹4.05 T
P/E Ratio
37.14
EPS
45.56
Dividend Yield
0.95%
Translate